List of PDMP websites

A listing of useful PDMP-related websites, including: PDMP account registration, query, and data upload, PDMP statistics, Opioid Dashboard, PDMP user training, statutes/regulations, and opioid prescribing guidelines.

Analysis of prescription opioid overdose death statistics 2017-2021

Analysis of prescription opioid overdose death statistics 2017-2021

PDMP Policies and Capabilities: Results From 2023 State Assessment

This document summarizes the status of PDMPs, based on the results of the 2023 state assessment, related to operations, policies/procedures, technological capabilities, and authorized users.

This document provides a general overview of how prescription drug monitoring programs (PDMPs) operate.

This document provides a general overview of how prescription drug monitoring programs (PDMPs) operate.

Guidance for PDMPs on research requests and outreach

The misuse of prescription drugs, especially opioids, has become a national crisis. The opioid epidemic creates a public health and safety concern that requires innovative solutions. One potential solution is the use of prescription drug monitoring programs (PDMPs). Research on the use of PDMPs provides evidence-based outcomes that can help inform decisions around public policy and provide insight into potential strategies to address the opioid crisis. PDMPs help detect fraud and provide valuable data that can be used to better understand the scope of the epidemic and the impact of various interventions. Research can also inform strategies for use of PDMPs to decrease opioid misuse and improve public health and safety.

PDMP Policies and Capabilities: Results From 2022 State Assessment

This document summarizes the status of PDMPs, based on the results of the 2022 state assessment, related to operations, policies/procedures, technological capabilities, and authorized users.

This video podcast will provide an overview of Prescription Drug Monitoring Programs.

This video podcast will provide an overview of Prescription Drug Monitoring Programs.

A copy of the transcipt is available here.

This report details the areas where prescription data errors may occur, some procedures PDMPs employ to detect those errors, and steps to ensure that the erroneous data are corrected.

Complete and accurate prescription drug information is vitally important to support efforts to reduce the incidence of prescription drug misuse and diversion. Healthcare providers (prescribers and dispensers) have a vested interest in ensuring that quality data are transmitted to and available from prescription drug monitoring programs (PDMPs). This report examines promising practices for PDMPs in identifying the dispensers required to transmit prescription data, effective ways to monitor dispensers’ compliance, and how to provide dispensers with information about what data should be transmitted and how. It also examines where data errors may potentially occur and how PDMPs may identify the errors and processes to ensure timely corrective actions. This report details the areas where prescription data errors may occur, some procedures PDMPs employ to detect those errors, and steps to ensure that the erroneous data are corrected. In addition, it provides suggestions for prescribers, dispensers, and other stakeholders to prevent data errors from occurring. 

Analysis of prescription opioid overdose deaths from 2016 through 2020.

The PDMP Training and Technical Assistance Center (TTAC) compiled overdose death statistics from 1999 to 2020. PDMP TTAC analyzed the overdose statistics was to identify state efforts that were most effective in reducing the incidence of prescription opioid overdose deaths. 

Recommended Best Practices for Veterinary Prescriptions

PDMP TTAC collaborated with representatives from the National Association of State Controlled Substances Authorities (NASCSA) PMP Committee to provide guidance surrounding veterinary prescription reporting to prescription drug monitoring programs (PDMPs). The “Recommended Best Practices for Veterinary Prescriptions” report examines the issues facing PDMPs as it relates to veterinarians and offers suggestions on how PDMPs may best address them. The suggestions are a consensus reached as result of the TTAC/NASCSA work group’s efforts and is intended to:

• show reporting issues of veterinary dispensing and prescribing,
• find issues in displaying such data in PDMP reports and queries, and
• offer recommended best practices on techniques and policies for PDMPs.

PDMP Policies and Capabilities: Results From 2021 State Assessment

This document summarizes the status of PDMPs, based on the results of the 2021 state assessment, related to operations, policies/procedures, technological capabilities, and authorized users.

FAQs for 42 CFR Part 2 and PDMPs

Patient privacy and confidentiality is extremely important for patient outcomes and it is also the law. Federal and state privacy laws, including those applicable to prescription drug monitoring programs (PDMPs), provide protection for patients who seek or obtain medical care, and there are heightened legal protections for the privacy substance use disorder (SUD) treatment information. 42 CFR Part 2 (known as “Part 2”) serves to protect patient records created by certain federally assisted programs for SUD treatment.
These regulations, “Confidentiality of Substance Use Disorder Patient Records,” were first promulgated in 1975 to address concerns about the potential use of SUD information against patients. 42 CFR Part 2 regulations are intended to ensure that a patient receiving SUD treatment from a 42 CFR Part 2 Program does not face adverse consequences.

Summary of results of the 2020 state assessment.

Since 2010, the PDMP Training and Technical Assistance Center (TTAC), at the Institute for Intergovernmental Research (IIR), with support from the Bureau of Justice Assistance (BJA), has conducted seven (7) state assessments of prescription drug monitoring programs (PDMPs). The assessments have gathered data on PDMP statutes, regulations, policies, and procedures; tracked their changes over time; and identified program trends and candidate best practices. This document details the current status of PDMPs, based on the results of the 2020 state assessment, related to operations, policies/procedures, technological capabilities, authorized users, and PDMP reports.

This report examines the issues facing PDMPs as they relate to veterinarians and provide suggestions on how PDMPs may best address these issues.

This Technical Assistance Guide (TAG) is intended to (1) identify reporting issues of veterinary dispensing and prescribing, (2) identify issues in displaying such data in PDMP reports and queries, and (3) provide recommended best practices on techniques and policies for PDMPs.

The document tells the history of PDMPs from the earliest programs up to the present time. Prescription drug monitoring programs are designed to facilitate the collection, analysis, and reporting of information on the prescribing, dispensing, and use of prescription drugs within a state. An overriding goal of PDMPs is to uphold both the state laws ensuring access to appropriate pharmaceutical care by citizens and the state laws deterring diversion. While in recent years PDMPs have gained notoriety and have been recognized as important programs, it was not always that way. The history of PDMPs spans almost a century and is riddled with opposition, misperception, and misinformation regarding their purpose and value.

This package is for PDMP Administrators to use as a guidance and reference tool. There has been growing concern among PDMP Administrators about the misinformation and misperception being disseminated at all levels regarding the workings and operations of these programs. PDMP Administrators around the country identified the need for the creation of an orientation package for new PDMP Administrators. This package could be used by new and less experienced PDMP Administrators as a guidance and reference tool.